4Scozzafava A, Mastrolorenzo A, Supuran CT. Non - peptidic chemokine receptors antagonists as emerging anti -HIV agents[J]. J Nnzyme Inhib Med Chem,2002, 17(2) :69 -76.
5Hirsch MS,Bran - Vezinet FD, Aquila RT, et al. Antiretroviral drug resistance testing in adult HIV - 1 infection: recommendations of an International AIDS Society- USA Panel[J]. J Am Med Assoc, 2000,283( 18):2417-2426.
6Babe LM, Rose J, Craik CS. Trans - dominant inhibitory human immunodeficiency virus type 1 protease monomers prevent protease activation and virion maturation. Proc Natl Acad Sci USA, 1995,92 (22) :10069 - 10073.
7Molla A,Granneman GR, Sun E,et al. Recent developments in HIV protease inhibitor therapy [ J ]. Antivir Res, 1998,39 ( 1 ) : 1 - 23.
8Churchill DR, Pym AS, Babiker AG, et al. Hyperlipidemia following treatment with protease inhibitor in patients with HIV - 1 infection[J]. Br J Clin Pharmacol,1998,46(5):518 -519.
9Sun LQ, Ely JA, Gerlach W, et al. Anti - HIV ribozymes[J]. Mol Biotechnol, 1997,7(3) :241 - 251.
10Sarver N ,Cantin EM,Chang PS,et al. Ribozymes as potential anti - HIV -1 therapieutic agents[J], Science, 1990,247(4974) : 1222 - 1225.
